1.
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analys...
by Franko, Jan, Dr
The lancet oncology, 2016, Vol.17 (12), p.1709-1719

2.
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
by Koopman, Miriam, MD
The Lancet (British edition), 2007, Vol.370 (9582), p.135-142

3.
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of...
by Meulendijks, Didier, PharmD
The lancet oncology, 2015, Vol.16 (16), p.1639-1650

4.
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
by Simkens, Lieke H J, MD
The Lancet (British edition), 2015, Vol.385 (9980), p.1843-1852
